Nordea Investment Management Reduces $157M in Becton, Dickinson and Company ($BDX)

Nordea Investment Management has cut its stake in Becton, Dickinson and Company (NYSE: BDX) by about 31%, according to its latest 13F filing with the SEC. The firm sold 1,092,124 shares, bringing its total holdings to 2,435,206 shares, valued at roughly $350.6 million as of the reporting period.

What Changed in Nordea Investment Management's Becton, Dickinson Position

Nordea Investment Management's recent filing shows a significant reduction in its Becton, Dickinson position. The firm previously held 3,527,330 shares and has reduced this by 1,092,124 shares, a 31% decrease. The remaining 2,435,206 shares are valued at approximately $350.6 million.

Other Institutional Activity in Becton, Dickinson

Other major institutional players also adjusted their positions in Becton, Dickinson. BlackRock, Inc. reduced its holdings by 9,015,742 shares, ending with 26,153,411 shares worth about $4.11 billion. Vanguard Capital Management LLC, on the other hand, increased its position by 18,490,610 shares, resulting in a total of 18,490,610 shares valued at around $2.91 billion. Similarly, Vanguard Portfolio Management LLC added 15,317,242 shares, reaching a total of 15,317,242 shares valued at approximately $2.41 billion. Meanwhile, State Street Corp decreased its stake by 3,971,368 shares, holding 13,822,808 shares worth $2.17 billion.

Becton, Dickinson Stock Snapshot

Shares of Becton, Dickinson (NYSE: BDX) are trading near $143.98. The company has a market capitalization of approximately $39.67 billion and a P/E ratio of 25.13. Its forward P/E is 10.75, and it carries a beta of 0.278, indicating lower volatility compared to the market. The stock's 52-week range is between $127.59 and $187.35, with moving averages of $148.96 (50-day) and $154.07 (200-day). Becton, Dickinson has a current ratio of 0.942 and a quick ratio of 0.355, with a debt-to-equity ratio of 71.6.

Recent Earnings

Becton, Dickinson reported revenue of $22.23 billion, reflecting a growth of 5.2%. The company's net margin stands at 5.12%, with a return on equity of 6.67%. Earnings per share came in at $5.73. The company is expected to release its next earnings report on August 6, 2026.

Dividend

Becton, Dickinson offers an annual dividend rate of $4.20, yielding 2.89% based on current prices. The dividend payout ratio is 72.95%.

Insider Buying and Selling at Becton, Dickinson and Company

Several insiders have been active in trading Becton, Dickinson shares. On June 10, 2026, EVP & President of Medical Essentials & BioPharma, Michael David Garrison, sold 1,100 shares at an average price of $151.48 under a planned transaction. On June 1, 2026, CEO Thomas Polen Jr. executed multiple transactions, including selling 17,445 shares at $146.15 and 2,764 shares at $146.35, while also purchasing 20,209 shares at $126.16. EVP and President of BDI, Peter Menziuso, acquired 14,258 shares on the same day.

Analysts Set New Price Targets

Analysts have maintained mixed ratings on Becton, Dickinson. On May 11, 2026, Barclays maintained a "buy" rating with a $204 price target. Wells Fargo maintained a "hold" rating with a $161 target on May 8, 2026, and TD Cowen kept a "hold" rating with a $163 target on May 4, 2026. The consensus recommendation is a "buy" with an average target price of $180.69 from 13 analysts.

About Becton, Dickinson and Company

Becton, Dickinson and Company, headquartered in Franklin Lakes, New Jersey, is a global leader in medical technology. The firm develops, manufactures, and sells a wide range of medical supplies, devices, laboratory equipment, and diagnostic products. Its offerings serve healthcare institutions, life science researchers, and the general public. The company operates through segments like Medical Essentials, Connected Care, BioPharma Systems, Interventional, and Life Sciences. Led by CEO Thomas E. Polen Jr., Becton, Dickinson employs around 60,000 people worldwide.

Bottom Line

Nordea Investment Management's reduction in its Becton, Dickinson stake is part of its latest 13F filing, reflecting holdings as of the reporting period. Investors track such filings to gauge fund sentiment and strategy shifts. While institutional moves are backward-looking, they offer insights into potential trends and fund management strategies.